论文部分内容阅读
原发性甲状旁腺机能亢进症的发病率日渐增多,Heath等报告为51.5±9.6例/10万人口。此病目前均需外科手术治疗,由于甲状旁腺位置及数目颇多变异,又常易与邻近脂肪组织发生混淆,故易误诊或漏诊。显然,术中甲状旁腺病灶(如腺瘤、增生或腺癌等)的精确定位,是治疗成败的关键。一、术中定位方法术前1小时,静脉滴注美篮注射液Me-thyleneblue),用量为5mg/公斤,加入5％葡萄糖生理盐水500ml内,手术开始前滴注完毕。术中可见,甲状旁腺病灶即被染成清晰的暗蓝色,因周围组织不着色,故极易识别。
The incidence of primary hyperparathyroidism is increasing, and Heath et al. reported 51.5±9.6 cases per 100,000 population. The disease is currently required to undergo surgical treatment. Because the position and number of parathyroid glands are quite variable, they are often confused with adjacent adipose tissue. Therefore, they are often misdiagnosed or missed. Obviously, accurate positioning of intraoperative parathyroid lesions (such as adenoma, hyperplasia, or adenocarcinoma) is the key to successful treatment. First, the intraoperative positioning method 1 hour before surgery, intravenous infusion of the United States and the basket injection Me-thyleneblue), the amount of 5mg/kg, add 5% glucose saline 500ml, the operation is completed before the infusion. It can be seen during surgery that the lesions of the parathyroid glands are clearly stained with dark blue, and the surrounding tissue is not colored, so it is easy to identify.